Researchers identify high-IgA MASLD subtype linked to liver-related events

AI Summary

Researchers have identified a high-IgA subtype of metabolic dysfunction-associated steatotic liver disease that is linked to liver-related events. The work suggests that patients may face serious outcomes even without advanced fibrosis, pointing to additional ways to assess disease progression and risk.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition that can follow very different paths among patients. Although fibrosis is a key indicator, some patients without advanced fibrosis can still develop serious liver-related events. This variation led researchers to investigate whether distinct clinical subtypes of MASLD could reveal additional clues about disease progression and risk.